使用菠萝蛋白酶制剂NexoBrid®进行酶性清创的烧伤创面微生物特征
该研究在Pinderfields区域烧伤中心于2016年7月至2019年2月期间,比较了使用NexoBrid®酶性清创的烧伤创面与同期接受手术清创或仅敷料治疗的烧伤创面的细菌出现情况。结果显示,NexoBrid®治疗创面的微生物特征与未行酶性清创的广泛报道相似,均表现为第一周以革兰阳性菌为主、第二周以革兰阴性菌为主。
要点
- NexoBrid®酶性清创后烧伤创面微生物特征与未行酶性清创者相似。
- 创面愈合各阶段均显示第一周革兰阳性菌为主、第二周革兰阴性菌为主。
- 研究比较了酶性清创、手术清创和仅敷料治疗的创面细菌出现情况。
核心结论
- 使用NexoBrid®治疗的烧伤创面微生物特征与未行酶性清创的广泛报道相似,贯穿创面愈合各阶段。
研究设计与样本
- 研究分析了2016年7月至2019年2月期间在Pinderfields区域烧伤中心接受酶性清创的烧伤创面细菌出现情况,并与同期接受手术清创或仅敷料治疗的创面细菌特征进行比较。
主要发现
- NexoBrid®治疗创面的微生物特征与未行酶性清创者相似,表现为第一周革兰阳性菌为主、第二周革兰阴性菌为主。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The antimicrobial properties of bromelain have been previously studied. However, the effect of enzymatic debridement on bacterial colonisation in burn wounds was not described in literature. In this study, we examine whether bromelain-based enzymatic debridement using NexoBrid® gel alters the microbiological pattern of burn wounds. Bacterial emergences in burn wounds that were enzymatically debrided at Pinderfields Regional Burns Centre, between July 2016 and February 2019, were studied and compared to the bacterial profile of burn wounds that were managed either by surgical debridement or dressings only during the same period. Our results showed that the microbial profile of burn wounds treated with NexoBrid® is similar to what is widely reported in cases treated without enzymatic debridement, at all stages of wound healing. This particularly showed in the predominance of Gram-positive organisms in the first week and Gram-negative in the second week.
引用
- Sharaf A, Muthayya P. Microbial profile of burn wounds managed with enzymatic debridement using bromelain-based agent, NexoBrid®. Burns. 2021. PMID: 34973852. doi:10.1016/j.burns.2021.12.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。